Samsung Biologics, a contract development and manufacturing organization (CDMO), has been awarded a “gold” rating from EcoVadis, a sustainability ratings provider. According to officials, Samsung Biologics is now among the top 5% of the more than 100,000 companies worldwide that were assessed by the provider.
“Achieving an EcoVadis Gold rating is further indication of Samsung Biologics’ strengthened ESG focus and our commitment to working with our suppliers and industry partners to reduce our environmental impact, integrate sustainable management, and build a more transparent, responsible value chain,” comments John Rim, CEO and president of Samsung Biologics. “Not only is prioritizing these efforts within our business the right thing to do, but it is also an important part of what we bring to our clients to help them meet their own sustainability commitments.”
The CDMO recently published its annual ESG report, discussing its environmental management strategy that outlines various activities to reduce emissions, such as process energy optimization, transitioning to renewable energy, and limiting the use of disposables in the manufacturing process through waste management and recycling.